These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12857662)
1. Research advances in the understanding and treatment of addiction. O'Brien CP Am J Addict; 2003; 12(s2):S36-S47. PubMed ID: 12857662 [TBL] [Abstract][Full Text] [Related]
2. Substance abuse and schizophrenia: pharmacotherapeutic intervention. Green AI; Noordsy DL; Brunette MF; O'Keefe C J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793 [TBL] [Abstract][Full Text] [Related]
4. [Acamprosate and naltrexone: similar efficacy for relapse]. Saitz R Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019 [No Abstract] [Full Text] [Related]
5. Medicaid coverage of medications to treat alcohol and opioid dependence. Mark TL; Lubran R; McCance-Katz EF; Chalk M; Richardson J J Subst Abuse Treat; 2015 Aug; 55():1-5. PubMed ID: 25921475 [TBL] [Abstract][Full Text] [Related]
6. New pharmacological treatment strategies for relapse prevention. Spanagel R; Vengeliene V Curr Top Behav Neurosci; 2013; 13():583-609. PubMed ID: 22389180 [TBL] [Abstract][Full Text] [Related]
7. Addiction medicine for the primary care physician. Yarborough WH J Okla State Med Assoc; 2001 Nov; 94(11):499-506. PubMed ID: 11729596 [TBL] [Abstract][Full Text] [Related]
8. Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India. Basu D; Jhirwal OP; Mattoo SK Am J Addict; 2005; 14(4):381-95. PubMed ID: 16188718 [TBL] [Abstract][Full Text] [Related]
9. Acamprosate for the treatment of alcohol dependence. Boothby LA; Doering PL Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977 [TBL] [Abstract][Full Text] [Related]
10. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. Rösner S; Leucht S; Lehert P; Soyka M J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials. Snyder JL; Bowers TG Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575 [TBL] [Abstract][Full Text] [Related]
12. Addiction pharmacotherapy 2000: new options, new challenges. Rawson RA; McCann MJ; Hasson AJ; Ling W J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198 [TBL] [Abstract][Full Text] [Related]
13. Addiction treatment: level of care determination. Alam DA; Martorana A Prim Care; 2011 Mar; 38(1):125-136. PubMed ID: 21356425 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic approaches to the management of alcoholism. Anton RF J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870 [TBL] [Abstract][Full Text] [Related]
15. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland. Buri C; Moggi F; Giovanoli A; Strik W Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820 [TBL] [Abstract][Full Text] [Related]
16. Acamprosate campral for alcoholism. Med Lett Drugs Ther; 2005 Jan; 47(1199):1-3. PubMed ID: 15599336 [TBL] [Abstract][Full Text] [Related]
17. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347 [TBL] [Abstract][Full Text] [Related]
18. Combined therapy: what does acamprosate and naltrexone combination tell us? Kiefer F; Wiedemann K Alcohol Alcohol; 2004; 39(6):542-7. PubMed ID: 15456690 [TBL] [Abstract][Full Text] [Related]